Healthcare provider profile · identity verified

Megan Mcfaddin Jackson, NP

Nurse Practitioner · GREENSBORO, GA · NPI 1821513342

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	181	41
Atorvastatin Calcium	Atorvastatin Calcium	167	54
Amlodipine Besylate	Amlodipine Besylate	144	43
Omeprazole	Omeprazole	137	31
Lisinopril	Lisinopril	119	28
Trazodone Hcl	Trazodone Hcl	100	25
Hydrochlorothiazide	Hydrochlorothiazide	94	24
Meloxicam	Meloxicam	88	29
Alprazolam	Alprazolam	86	14
Levothyroxine Sodium	Levothyroxine Sodium	86	24
Ozempic	Semaglutide	85	15
Montelukast Sodium	Montelukast Sodium	83	20
Rosuvastatin Calcium	Rosuvastatin Calcium	82	32
Pantoprazole Sodium	Pantoprazole Sodium	80	26
Metformin Hcl	Metformin Hcl	78	26
Fluticasone Propionate	Fluticasone Propionate	77	25
Pregabalin	Pregabalin	76	13
Tramadol Hcl	Tramadol Hcl	69	20
Amitriptyline Hcl	Amitriptyline Hcl	68	suppressed
Mounjaro	Tirzepatide	66	suppressed
Furosemide	Furosemide	62	23
Albuterol Sulfate Hfa	Albuterol Sulfate	61	20
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	60	suppressed
Losartan Potassium	Losartan Potassium	58	22
Metoprolol Succinate	Metoprolol Succinate	56	18
Clonazepam	Clonazepam	53	suppressed
Metformin Hcl Er	Metformin Hcl	53	suppressed
Methylprednisolone	Methylprednisolone	53	46
Carvedilol	Carvedilol	50	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	20
Famotidine	Famotidine	50	15
Azithromycin	Azithromycin	49	39
Sertraline Hcl	Sertraline Hcl	49	15
Glimepiride	Glimepiride	48	15
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	12
Simvastatin	Simvastatin	45	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Allopurinol	Allopurinol	43	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	43	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	34
Ondansetron Odt	Ondansetron	41	17
Synthroid	Levothyroxine Sodium	39	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	38	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Linzess	Linaclotide	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	12
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Jardiance	Empagliflozin	32	suppressed
Prednisone	Prednisone	32	12
Acetaminophen-Codeine	Acetaminophen With Codeine	31	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Fluconazole	Fluconazole	29	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Estradiol	Estradiol	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Promethazine Hcl	Promethazine Hcl	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	12
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	20
Eliquis	Apixaban	23	suppressed
Rybelsus	Semaglutide	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Lidocaine	Lidocaine	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	19
Nystatin	Nystatin	21	11
Potassium Chloride	Potassium Chloride	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Topiramate	Topiramate	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Lorazepam	Lorazepam	16	suppressed
Minoxidil	Minoxidil	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Atenolol	Atenolol	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Glipizide	Glipizide	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Metronidazole	Metronidazole	15	12
Temazepam	Temazepam	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Mometasone Furoate	Mometasone Furoate	13	suppressed
Primidone	Primidone	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Diazepam	Diazepam	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Ramipril	Ramipril	12	suppressed
Valsartan	Valsartan	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Ramelteon	Ramelteon	11	suppressed
Rexulti	Brexpiprazole	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error